New high for cannabinoids

Consortium seeks to clear up contradictory data from CNR2 agonists

A consortium of academic and industry scientists have joined forces to help separate the signal from the noise in translational studies of the cannabinoid CB2 receptor (CNR2) by benchmarking the 18 most commonly used agonists against an extensive battery of molecular pharmacology tests. The findings, described last

Read the full 470 word article

User Sign In